Stay updated on Nivolumab Combo for Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Combo for Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check20 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study page now renders a 403 Forbidden error, replacing the previous study record content with an error screen. As a result, the trial details, locations, and related information are no longer accessible on the page.SummaryDifference18%

- Check69 days agoChange DetectedA new funding/identifier line '2015 ( U.S. NIH Grant/Contract )' was added to the study's identifiers. The page revision note updated to v3.6.6, replacing v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo for Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo for Uveal Melanoma Clinical Trial page.